Kenneth Galbraith has joined Ventures West as a venture partner focused on life sciences opportunities. Last year he served as chairman and interim CEO of AnorMED, until its $600 million cash sale to Genzyme. www.ventureswest.com
Return to search
![]()
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.